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Abstract
Amajor obstacle to an effective myocardium stem cell therapy has always been the delivery
and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells
are administered as cell aggregates, which maintain their extra-cellular matrix (ECM). We
have generated spheroid aggregates in less than 24 h by seeding human cardiac progenitor
cells (hCPCs) onto methylcellulose hydrogel-coated microwells. Cells within spheroids
maintained the expression of stemness/mesenchymal and ECMmarkers, growth factors
and their cognate receptors, cardiac commitment factors, and metalloproteases, as
detected by immunofluorescence, q-RT-PCR and immunoarray, and expressed a higher,
but regulated, telomerase activity. Compared to cells in monolayers, 3D spheroids secreted
also bFGF and showed MMP2 activity. When spheroids were seeded on culture plates, the
cells quickly migrated, displaying an increased wound healing ability with or without phar-
macological modulation, and reached confluence at a higher rate than cells from conven-
tional monolayers. When spheroids were injected in the heart wall of healthy mice, some
cells migrated from the spheroids, engrafted, and remained detectable for at least 1 week
after transplantation, while, when the same amount of cells was injected as suspension, no
cells were detectable three days after injection. Cells from spheroids displayed the same
engraftment capability when they were injected in cardiotoxin-injured myocardium. Our
study shows that spherical in vivo ready-to-implant scaffold-less aggregates of hCPCs able
to engraft also in the hostile environment of an injured myocardium can be produced with an
economic, easy and fast protocol.
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Introduction
The demonstration that all tissues in the organism contain stem cells has opened to the new
possibility of cell therapy and regenerative medicine in case of organ injury [1]. Stem cell trans-
plantation has proven to be a promising strategy for the treatment of ischemic cardiovascular
diseases [2], which are the leading cause of mortality and morbidity worldwide and have high
socioeconomic costs [3,4]. The recently developed cell therapies, aimed at replacing the injured
lost myocardial cells, may provide new opportunities to treat cardiac infarct, and indeed clini-
cal trials have already started, although so far with modest results [5,6].
When applying cell therapy to an injured organ, a crucial point is the conformation to the
properties of the damaged tissue to be repaired or replaced. Thus, the cell type and the way or
the form for their delivery have a pivotal role. In the case of myocardium, among the various
cell types that have been proposed as candidates the cardiac progenitor cells (CPC) seems to be
the most promising [2]. In fact, other cell sources, like skeletal muscle satellite cells, bone mar-
row derived mesenchymal stem cells, adipose tissue derived mesenchymal stromal cells, amni-
otic fluid derived cells, do not properly integrate within the myocardium [2].
The potential of CPCs is likely related to the fact they are already committed to their destiny
[2], having received the influence of the cardiac environment, and thus are more prone to dif-
ferentiate towards the required phenotype. Indeed they are responsible for the myocardial
homeostasis throughout lifetime [7]. CPCs still retain their multipotency, being able to give ori-
gin also to endothelial and smooth muscle cells, besides cardiomyogenic cells [8].
Human CPCs (hCPCs) are generally identified for the expression of biochemical markers,
such as c-kit, MDR, Sca-1, NKX2.5, CD105 [8–10], whose expression, however, is not restricted
to this cell population and in some cases was found to be unstable [9,11]. For this reason, the
identifying criteria for hCPCs are still debated. hCPCs can be identified also on the basis of
functional properties, such as the ability to form cardiospheres [12]. Notwithstanding these
uncertainties, clinical trials with hCPCs are already under way [5,6,13].
As already pointed out, the form and the method of in vivo delivery plays a key role for a
successful engraftment. Indeed, since the first in vivo cell injection experiments and treatments
for cardiac repair it has been evident that most cells are lost in the first 24 hours, and that their
engraftment was always inadequate [14]. To overcome these limitations, therapies were pur-
sued by ex vivo cardiac tissue engineering to produce 3D structures containing the cellular
component supported by a biomimetic scaffold [15–17]. The possibility to produce scaffold-
less multicellular aggregates, such as cardiospheres, which are obtained by expanding clonal
derived cells as self-adherent clusters in suspension [12], or purposely produced cell sheets
[18–20] and sheet fragments [21], from which cells migrate and establish contacts with the res-
ident cells in the myocardium, opened new possibilities since, in principle, the inflammatory
reaction triggered by the scaffold should be avoided. Moreover, the extracellular matrix pro-
duced by these cells is not lost as a consequence of the enzymatic processing necessary for the
recovery of the cells to be transplanted as cell suspension; on the contrary, it should favour
their adhesion to the myocardium and survival, although still in a low number [22]. These
observations have suggested a beneficial effect most probably due to a paracrine indirect mech-
anism, rather than a direct structural involvement [23]. Both cardiospheres and cell sheets
require relatively long-term cultures and expensive reagents. A cell culture system employing
methylcellulose (MC) hydrogel wells was reported to allow the production of implantable
spherical clusters made of rat bone marrow mesenchymal stem cells [24–26] and human amni-
otic cells [27].
The advantage of this method is that spherical symmetric spheres can be obtained in less
than 24 h, with low cost reagents and with an easy approach. We have thus decided to investigate
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whether such a strategy could apply also to hCPCs. Cells within spheroids were found to main-
tain the properties of the original cells cultured as 2Dmonolayers and, in the meantime, to dis-
play a higher migration potential and a better in vivo engraftment, both in healthy and in
cardiotoxin-injured myocardium.
Methods
Isolation of hCPCs and preparation of spheroids
hCPCs were isolated from samples of right auricula of patients (N = 8, age range: 50–86;
median age: 74.5±11.8; 5 males and 3 females), undergoing cardiac surgery at the Department
of Cardiac Surgery of the Clinic of St. Gaudenzio, Novara (Italy). Signed written informed con-
sents were obtained according to a protocol approved by the Institutional Review Board (IRB)
of Novara (Italy). (Comitato Etico Interaziendale, protocol #338/CE, study CARDIOCELL, CE
54/10, approved on June 22, 2010). Auricula fragments were processed as already described
[11,19]. Tissue fragments were plated on 0.02% gelatin-coated dishes in 1/3 Claycomb (Sigma
Aldrich, St. Louis, MO, USA) and 2/3 F12K (Invitrogen Life Technologies Italia, Monza MB,
Italy), 10% fetal bovine serum (FBS) (Lonza Biowittaker, Verviers, Belgium), 100 IU/ml peni-
cillin and 100 μg/ml streptomycin (Sigma Aldrich), and cultured at 37°C in 5% CO2. Cells
migrating from the fragments were sorted by magnetic immunobeads using anti-c-kit antibody
(Miltenyi Biotec GmbH, Germany). These cells were positive for c-kit, CD90, Sca-1, CD44,
CD105, and negative for CD34 and CD45 as previously reported, although c-kit expression
was lost after few passages [11,19]. Spheroids were prepared with cells grown for 5 to 7 passages
[11]. hCPCs were dissociated from culture dishes by trypsinization, then seeded drop-wise in
the multiwell methylcellulose and cultured for 24 h (12%MC, aqueous solution wt/vol) under
standard conditions. Hydrogel system was prepared as described [26,27]. Spheroids were pre-
pared using different amount of cells, ranging from 5x103 to 25x103. For this work, most of the
spheroids were produced with an average of 5x103. These spheroids had a size compatible for
the in vivo studies, since they were able to pass throughout a 27 gauge-needle maintaining full
cell viability and cells did not dissociate (Fig 1A).
Characterization and properties of hCPC spheroids
a) Morphological analysis. hCPC spheroids were analysed using a Leica DMRB micro-
scope equipped with a digital camera. Photomicrographs were taken and spheroid diameters
were measured by using a computer-based image analysis system (ImageJ, NIH, USA).
b) Cell viability. hCPCs viability within spheroids was evaluated with the Live-Dead Cell
Staining Kit (Biovision, Milpitas, California, USA). Freshly stained cells were analysed by laser
scanning confocal microscope (Leica TCS SP2, Heerbrugg, Switzerland). Live-Dead staining
was performed also after the passage of spheroids through a 27-gauge needle syringe, in order
to control cell viability, besides spheroid shape and size.
c) Immunofluorescence. hCPC spheroids were washed with phosphate buffer saline
(PBS), fixed with 3% paraformaldehyde (PFA) for 20 min, rinsed with PBS, and permeabilised
with 0.2% Triton X-100, 1% bovine serum albumin (BSA), 5% fetal bovine serum (FBS) in
phosphate buffered saline (PBS) for 2 h. Cells in monolayers and spheroids were incubated for
1 h with primary antibodies (listed in Table 1) dissolved in PBS-0.2% Triton X-100, 1% BSA,
then washed three times with PBS-0.2% Triton X-100, and incubated with the appropriate
FITC-conjugated (Abcam, Cambridge, MA, USA, excitation 488 nm and emission 520 nm)
secondary antibodies. Nuclei were stained with TO-PRO-31 (1/100, Life Technologies Italy,
excitation at 642 nm and emission at 661 nm), cytoskeletal actin was stained using Alexa Fluor
546-phalloidin ((1/200, Life Technologies Italy, excitation 556 nm and emission at 570 nm).
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Fig 1. Morphology and viability of hCPC spheroids. (A) hCPC spheroids obtained from 5x103, 10x103 or 25x103 cells before and after their passage
through a 27G needle (scale bar, 100 μm). (B) Viability of spheroids as evaluated in a Live/Dead assay (viable cells in green, PI-positive dead cells in red).
Scale bar, 100 μm. Four optical sections of the spheroids taken at different levels of the z-axis are reported. Live/Dead assay was performed also on 5x103
cells spheroids after passage through the needle (A, bottom). One representative out of the three experiments performed with similar results is shown.
doi:10.1371/journal.pone.0137999.g001
Table 1. Primary antibodies used for immunofluorescence.
Antigen Species Dilution Source Cat. No
Fibronectin Rabbit polyclonal 1/200 Sigma-Aldrich F3648
Connexin 43 Rabbit polyclonal 1/200 AbCam Ab11370
Collagen I Rabbit polyclonal 1/500 AbCam Ab34710
Vimentin Mouse monoclonal 1/40 Sigma-Aldrich V6630
Laminin Rabbit polyclonal 1/50 Dako Z0097
GATA-4 Rabbit polyclonal 1/100 AbCam Ab61170
MEF 2C Rabbit polyclonal 1/100 AbCam Ab64644
CD44 Rat monoclonal 1/10 BioLegend 103021
CD90 Mouse monoclonal 1/10 BioLegend 328108
CD117/c-kit Mouse monoclonal 1/10 BioLegend 323404
Yap Rabbit polyclonal 1/100 Santa Cruz 15407
Met Mouse monoclonal 1/100 Property Prat, 1991)
Sca-1 Mouse monoclonal 1/50 Ebioscience 14-5981-85
Human nuclear antigen Mouse monoclonal 1/100 Millipore mAb 1281
doi:10.1371/journal.pone.0137999.t001
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Fluorescence was detected using a Leica TCS SP2 AOBS spectral confocal scanner microscope.
ImageJ software was used for image analysis.
d) Quantitative real-time PCR (qPCR). Total RNA was extracted in Trizol1 (Invitrogen
Life Technologies Italy), followed by DNAse treatment (DNAse I) (Fermentas, St. Leon-Rot,
Germany). Then, 1 μg RNA was retrotranscribed in cDNA with the RevertAid™HMinus First
Strand cDNA Synthesis Kit (Fermentas) using the oligo(dT) primers. Each gene expression
was normalized on the housekeeping gene ribosomal 18S rRNA. Analysis were based on the
methods previously described and adapted in our laboratory [11]. Briefly, assays were per-
formed in triplicate for each treatment in a 20 μl reaction volume containing 1 μl of RT prod-
ucts, 10 μl Sso-Fast EVA Green SMX (Bio-Rad), 500 nM each forward and reverse primers, as
indicated in Table 2. An automated CFX96 real-time thermocycler was used (Bio-Rad). The
reaction conditions were 95°C for 1 minute, followed by 45 cycles 98°C for 5 seconds and
anneal–extend step for 5 seconds at 60°C (Table 2), with data collection. At the end of these
cycles, a melting curve (65°C to 95°C, with plate read every 0.5°C) was performed in order to
assess the specificity of the amplification product by single peak melting temperature verifica-
tion (e.g. 18S rRNA melting temperature peak was 86°C). Results were analysed with Bio-Rad
CFXManager and exported to Excel (Microsoft, Redmond, WA, USA) for calculation and sta-
tistical analyses.
e) Growth Factors and receptors protein array. Cell culture media were collected from
hCPCs monolayers and spheroids kept in serum free medium for two days. Extracts were pre-
pared by lysing cells with iced RIPA buffer (20mM Tris-HCl pH 7.5, 150mMNaCl, 50mM
HEPES, 0.1% SDS, 1mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5mM sodium pyro-
phosphate, 10% glycerol, and a cocktail of protease inhibitors (Sigma- Aldrich)). Protein
content was quantified by Bicinchoninic acid (BCA; Sigma-Aldrich) assay. Both culture super-
nantants and cell extracts were analysed for their content of growth factors and receptors by
incubation on membranes of the RayBio1 C-Series Human Growth Factor Antibody Array C1
kit (RayBiotech, Norcross, GA, USA), following manufacturer’s instructions (see Table 3 for
array map). Briefly, after incubation with blocking buffer, undiluited culture media or 140 μg
of proteins extracted from cells were incubated on the kit membranes overnight at 4°C. Several
washes were performed and the biotinylated antibody cocktail was added for 2 hours at room
temperature followed by a HRP-streptavidin incubation. A chemiluminescence imaging system
was used to collect the data and analysis were performed by using a computer-based image
analysis system (ImageJ, NIH, USA).
f) Metallo proteases (MMP) activity (zymography). Cell culture supernatants as well as
cell lysates prepared as above and clarified by centrifugation (15,000 rpm at 4°C for 15 min;
30μg of protein) were dissolved in non reducing Laemmli buffer and loaded on 8% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) co-polymerized with the
MMP substrate (20 mg/ml of gelatin, 1% w/v SDS). After electrophoresis, gels were washed
twice for 1 hour in 2.5% Triton X-100, incubated overnight at 37°C in incubation buffer (50
mM Tris-HCl, 0.15M NaCl, 10 mM CaCl2), fixed, stained in 0.5% Coomassie Blue and
destained in 50% methanol– 70% acetic acid. Pictures were taken with a Gel Doc 1000 BioRad.
Data were analysed by a computer-based image analysis system (ImageJ, NIH, USA).
g) Telomere assay with multiplex-qPCR (MMQPCR). For the analyses of telomere
length variations in the different data set, we used a method based on Cawthon’s, with some
modifications [28]. Reactions were carried on by mixing 20 ng of genomic DNA, extracted
with Wizard1 Genomic DNA Purification Kit (Promega, Milan, Italy), 1x SsoFast EvaGreen
Supermix (Bio-Rad), telomere primers (Table 2) in a final volume of 20μl per reaction. An
automated CFX96 real-time thermocycler was used (Bio-Rad). The thermal profile and cycling
included a first step of 98°C for 2 minutes, for heat-activation of SsoFast EvaGreen Supermix
Injectable Human Cardiac Progenitor Cell Spheroids
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Table 2. Primers used for qPCR.
Gene Sequence (5’– 3’)
18S rRNA Fw GTGGAGCGATTTGTCTGGTT
Rv ACGCTGAGCCAGTCAGTGTA
β-ACTIN Fw ACTTCGAGCAAGAGATGGCC
Rv CACATCTGCTGGAAGGTGG
β-GLOBIN Fw CGGCGGCGGGCGGCGCGGGCTGGGCGGCTTCATCCACGTTCACCTTG
Rv GCCCGGCCCGCCGCGCCCGTCCCGCCGGAGGAGAAGTCTGCCGTT
c-MET Fw GGGTCGCTTCATGCAGGTTGTGGT
Rv ATGGTCAGCCTTGTCCCTCCTTCA
COLLAGEN I Fw AAGGTCATGCTGGTCTTGCT
Rv GACCCTGTTCACCTTTTCCA
COLLAGEN IV Fw ACTCTTTTGTGATGCACACCA
Rv AAGCTGTAAGCGTTTGCGTA
FN1 Fw AGACCCCAGGCACCTATCAC
Rv TCGGTCACTTCCACAAACTG
GATA-4 Fw ACCTGGGACTTGGAGGATAGCAAA
Rv TCCCATCAGCGTGTAAAGGCATCT
HGF Fw ACGCTACGAAGTCTGTGACA
Rv CAAGAGTATAGCACCATGGC
HMBS Fw GGCAATGCGGCTGCAA
Rv GGGTACCCACGCGAATCAC
hTERT Fw GACGTGGAAGATGAGCGTG
Rv GACGACGTACACACTCATC
IGF-1 Fw CTTCAGTTCGTGTGTGGAGACAG
Rv CGCCCTCCGACTGCTG
IGF-1R Fw CTCCTGTTTCTCTCCGCCG
Rv ATAGTCGTTGCGGATGTCGAT
IGF-2R Fw GAGGGAAGAGGCAGGAAAG
Rv TGTGGCAGGCATACTCAG
ITGA1 Fw GGTTCCTACTTTGGCAGTATT
Rv AACCTTGTCTGATTGAGAGCA
ITGB4 Fw AGACGAGATGTTCAGGGACC
Rv GGTCTCCTCTGTGATTTGGAA
MEF-2C Fw GACTGTGAGATTGCGCTGAT
Rv CGTCTCCACGATGTCTGAGT
MEF-2D Fw CCCCTGCTGGAGGACAAGTA
Rv CCCCTGCTGGAGGACAAGTA
MMP-2 Fw GGCCCTGTCACTCCTGAGAT
Rv GGCATCCAGGTTATCGGGGA
MMP-14 Fw CCCTATGCCTACATCCGTGA
Rv TCCATCCATCACTTGGTTAT
NKX2.5 Fw CGCCGCTCCAGTTCATAG
Rv GGTGGAGCTGGAGAAGACAGA
SDF-1 Fw GGTGGAGCTGGAGAAGACAGA
Rv CAGCCGGGCTACAATCTGAA
CXCR4 Fw TGACGGACAAGTACAGGCTGC
Rv CCAGAAGGGAAGCGTGATGA
(Continued)
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(Bio-Rad) and a second step for anneal and extend the telomeres with 2 cycles of 15 seconds at
94°C and 15 seconds at 49°C. The following steps were made of 40 cycles of 15 s at 94°C, 10 sec-
onds at 62°C, 15 s at 72°C with signal acquisition, 15 s at 82°C with signal acquisition, and a
last step melting curve 70.0°C to 95.0°C with increment 0.5°C per second and plate read. The
72°C reads provided the threshold cycle values, determined from semilog amplification plots
(Ct) (log increase in fluorescence versus cycle number) for the telomeres, and the 82°C reads
measured the Ct values for the amplification of the single β-globin template product while telo-
mere product is fully melted. Results were analyzed with Bio-Rad CFXManager and exported
to Excel (Microsoft) for calculation. The data are expressed as the T/S ratio for each multiplex
data set, where T was the measured Ct describing copy number of the telomere template, and S
was the copy number of the single copy gene β-globin product used as the internal reference.
In vitro migration assay
Wound healing assays were performed on cells migrated from spheroids or cultured as mono-
layers. Cells were plated on 0.1% gelatine (Sigma Aldrich) coated culture plates [11], and once
reached confluence were further incubated in serum-free medium for 36 hours. Monolayers
Table 2. (Continued)
Gene Sequence (5’– 3’)
Telomere Fw ACACTAAGGTTTGGGTTTGGGTTTGGGTTTGGGTTAGTGT
Rv TGTTAGGTATCCCTATCCCTATCCCTATCCCTATCCCTAACA
VE-cad 2 Fw GGCATCTTCGGGTTGATCCT
Rv CCGACAGTTGTAGGCCCTGTT
VEGF Fw TGCAGATTATGCGGATCAAACC
Rv TGCATTCACATTTGTTGTGCTGTAG
VEGFR-1 Fw CAGGCCCAGTTTCTGCCATT
Rv TTCCAGCTCAGCGTGGTCGTA
VEGFR-2 Fw CCAGCAAAAGCAGGGAGTCTGT
Rv TGTCTGTGTCATCGGAGTGATATCC
VLA-4 Fw ATCTGACTCTGCCTTCAT
Rv CATTCCTCACCATCACTG
doi:10.1371/journal.pone.0137999.t002
Table 3. Antibody array scheme.
A B C D E F G H I J K L
1 POS POS NEG NEG AREG bFGF b-NGF EGF EGF R FGF-4 FGF-6 FGF-7
2 POS POS NEG NEG AREG bFGF b-NGF EGF EGF R FGF-4 FGF-6 FGF-7
3 GCSF GDNF GM CSF HB EGF HGF IGFBP 1 IGFBP 2 IGFBP 3 IGFBP 4 IGFBP 6 IGF-1 IGF-1
sR
4 GCSF GDNF GM CSF HB EGF HGF IGFBP 1 IGFBP 2 IGFBP 3 IGFBP 4 IGFBP 6 IGF-1 IGF-1
sR
5 IGF-2 GM CSF MCSF R NT-3 NT-4 PDGFR
alpha
PDGFR
beta
PDGF
AA
PDGF
AB
PDGF
BB
PLGF SCF
6 IGF-2 GM CSF MCSF R NT-3 NT-4 PDGFR
alpha
PDGFR
beta
PDGF
AA
PDGF
AB
PDGF
BB
PLGF SCF
7 SCF R TGF
alpha
TGF
beta
TGF
beta2
TGF
beta3
VEGF VEGF R2 VEGF R3 VEGF D BLANK BLANK POS
8 SCF R TGF
alpha
TGF
beta
TGF
beta2
TGF
beta3
VEGF VEGF R2 VEGF R3 VEGF D BLANK BLANK POS
doi:10.1371/journal.pone.0137999.t003
Injectable Human Cardiac Progenitor Cell Spheroids
PLOS ONE | DOI:10.1371/journal.pone.0137999 September 16, 2015 7 / 23
were then wounded with a plastic tips as described previously [29], washed with PBS and incu-
bated overnight in the same serum-free medium, with or without the HGF receptor agonist
mAb DO-24 [30,31] at different concentrations or with 20% FBS, as positive control. Cells
were finally fixed with 3% PFA in PBS and analysed with a Leica DMRB microscope equipped
with a digital camera. Migration ability was quantified by calculating the area of wound at time
0 (t0 time of wound) and 24 h after wound (t14). Normalization was obtained by the formula
[area(t0)–area (t24)]/area(t0). At least triplicates were quantified for each condition. Data are
reported as means ± SD.
In vivo experiments
A total of 35 C57Bl/6J female mice at the age of six to eight weeks, purchased from Charles
River (Research Models and Services, Calco, Italy). The health status of the animals was moni-
tored by a health surveillance program according to the guidelines throughout the experiments.
The mice were free of all viral, bacterial, and parasitic pathogens. All animals were housed in
groups of three to eight animals. Animals were kept in type 3 clear transparent plastic cages
(425 mm x 266 mm x 155 mm) with autoclaved dust-freesawdust bedding and two nestletsTM
(each 5 cm x 5 cm) consisting of cotton fibres as nesting material. Additionally, animals were
provided with a transparent plastic shelter. They were fed a pelleted and extruded mouse diet
ad libitum and had unrestricted access to drinking water. The light/dark cycle in the room con-
sisted of 12/12 h with artificial light. The temperature was 21 +/- 1°C, with a relative humidity
of 55+/- 10%, and the air pressure was controlled at 50Pa with 15 complete changes of filtered
air per hour (HEPA H 14 filter). The animal room was insulated to prevent electronic and
other noise. Mice treated with cyclosporine (25 μg/g) and antibiotics 2 days before the implant
and then every second day until 6 days after transplantation. Mice were allocated randomly to
one of the four treatment groups, 10 animals injected with spheroids, 10 animals injected with
cells in suspension (control), 5 animals were injected with cardiotoxin (CTX; 5 μl of a 10 μM
solution; Latoxan, France; Cod:L8102) and 10 animals were injected with cardiotoxin and
spheroids, an optimal compromise to obtain significant results and lowering the number of
used mice. All the procedures were carried out in double blind. Animals were anesthetized
with Avertin (0.2 ml/g) and mechanically ventilated by Minivent (Hugo Sacks, March-Hugstet-
ten, DE). Thoracotomy was performed via the forth left-intercostal space, the parietal pericar-
dium was partially removed and the left ventricle exposed, as described previously [19].
Spheroids (10 for a total cell number of 5x 104 in a volume of 20μl), and the same number of
hCPCs in suspension in the same volume, were injected using a 27 gauge-needle in the left ven-
tricle wall. Cardiac damage was induced by injection of CTX in the myocardium apex, as previ-
ously described [32]. Cardiospheres were injected near the damaged area shortly after (5 min
later). At different time points (1, 3 and 7 days) 3–5 mice for the different treatment group
were sacrificed by cervical dislocation, their hearts excised, and perfused with 4% PFA in PBS,
1.41 mM cadmium chloride, embedded in OCT solution (Bio-Optica, Milano, Italy), snap-fro-
zen, and cut in 5-μm sections. Five mice out of 35 (15%) died before the end of the experiment.
Tissue sections were stained with Hematoxilin Eosin (HE) or TRITC-phalloidin, mouse anti-
human nuclear antigen antibody (see Table 1), followed by FITC-conjugated secondary goat
anti-mouse Ig antibodies, rabbit anti-connexin 43 (see Table 1), followed by TRITC-conjugated
secondary anti- rabbit Ig antibodies (Alexa Fluor 546) and TO-PRO-31. Images were taken
using a digital scanner Pannoramic Midi 3D HISTEC KFT (Budapest, Hungary) (HE) or a
Leica TCS SP2 AOBS spectral confocal scanner microscope (Immunofluorescence). Animal
studies were performed according to the guidelines of the Animal Care and Use Committee of
the Università del Piemonte Orientale “A. Avogadro” Novara, Italy, following the Decree 116/
Injectable Human Cardiac Progenitor Cell Spheroids
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92 and the D.Ivo #26 of March 4, 2014. The project (n. 17/2013) was approved by the Comitato
Etico per la Sperimentazione Animale dell’Università del Piemonte Orientale “A. Avogadro”
(C.E.S.A.P.O) on June 22, 2013).
Statistical analysis
For qPCR and MMQPCR data were expressed as means±SEM from at least three independent
experiments, and analysed by unpaired Student’s t test to compare expression between spher-
oids and cultured cells groups. For wound healing data ANOVA ad Dunnett’s post-test were
performed. Statistical computations were performed in GraphPad Prism 4.03 (GraphPad Inc.,
USA) and values of p0.05 or lower were considered statistically significant.
Results
Characterization of hCPC spheroids
Spheroids, which were prepared using different number of cells, formed within 20–24 hours,
and displayed a relatively homogeneous and number-dependent size distribution (Fig 1A). In
view of their use for in vivo experiments, in which they were injected through a 27 gauge-nee-
dle, most of the experiments were performed with spheroids obtained from 5x103 cells, with a
diameter of about 100 μm (Fig 1A). Viability of cells within spheroids was typically 95–98%
(Fig 1B), which was maintained, together with their association in aggregates, also after their
passage through the 27 gauge-needle (Fig 1A). Spheroids made with more than 5x103 cells dis-
aggregated upon their passage through this needle (Fig 1A).
Cells within spheroids maintained the immunophenotype of the cells from which they were
originated [11,19]. Indeed, among others, spheroids expressed the stemness/mesenchymal
markers, c-Kit, Sca-1, CD90, CD44 and vimentin and the ECMmarkers collagen I, fibronectin
and laminin (Fig 2A). Moreover, they retained the expression of the cardiac markers connexin
43, GATA-4 and MEF2C, the two latter at lower levels, in agreement with what found in cells
in monolayers (Fig 2B, [11,19]). Finally, spheroids expressed also the Met/Hepatocyte Growth
Factor Receptor, and the YAP protein, which was recently shown to promote cardiomyocyte
proliferation [33]. These same proteins were expressed also in cells cultured as 2D monolayers,
as already previously reported [11,19] or shown herein for some markers (Fig 2B).
The expression of some of these genes, as well as others belonging to different functional
classes, was then analysed by qPCR in hCPCs spheroids and referred to that of hCPCs grown
in monolayers (Fig 3). No major differences were found in the genes examined in this assay
between spheroids and monolayers. GATA-4, MEF-2C and NKX2.5, which are markers of
committed and differentiated cardiomyocytes, were slightly down-regulated in spheroids,
where, however, there was an up-regulation of MEF-2D. The same tendency was observed also
when we analysed specific growth factors and their cognate receptors. In general these mole-
cules mediate cell homing, proliferation, survival, angiogenesis and motility [34–37]. In spher-
oids, SDF-1 was down-regulated, while its receptor CXCR4 was up-regulated. HGF and VEGF
were up-regulated, while their respective receptors, Met and VEGFR-1 and VEGFR-2 were
down-regulated. In the case of the IGF-1 system, both the ligands and the two receptors were
down-regulated. The variations were always within 6 folds, and, anyway, also when transcripts
were found decreased, the proteins were expressed at levels still detectable in immunofluores-
cence, as exemplified in the case of the Met protein. Similarly, molecules of the ECM, such as
Collagen I, Collagen IV and Fibronectin were down-regulated in spheroids. Also in this case,
Fibronectin transcripts were reduced to about 1/4 in spheroids, but still the protein was easily
detected in immunofluorescence. Among the receptors for ECMmolecules, which should be
involved in cell adhesion and migration [38,39], VLA-4 and ITGB4 were down-regulated,
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while ITGA1 was up-regulated. The VE-cad2 endothelial cadherin, which is essential for vascu-
lar development and integrity [40], was up-regulated in spheroids. The expression of different
growth factors and their receptors was evaluated also at protein levels both in serum-free
supernatants and cell extracts obtained from 2D and 3D cells cultures for 2 days by an antibody
array. This assay confirmed a significant expression and release of HGF and VEGF, while IGF-
1 was also detectable but at lower levels (Fig 4A). In particular, VEGF expression was higher in
the supernatants from spheroids, in accordance with the mRNA data, while HGF expression
was lower in comparison to cell monolayers, in contrast to what observed at mRNA analysis.
Other growth factors expressed at high levels were EGF, IGFBP-6, and GM-CSF in both 2D
and 3D culture supernantants, and bFGF and IGFBP-1 in 3D spheroid supernatants. The latter
two factors, as well as VEGF and PDGF-AA were expressed at significantly higher levels in
spheroids supernatants. We found that the biologic activity of HGF, as titrated in a scatter
assay performed on MDCK, the standard cell line used for this kind of assay [30], in the
Fig 2. Immunophenotype of hCPC-derived spheroids. (A) Confocal microscopy images of spheroids for mesenchymal/stromal, stemness, extracellular
matrix, and cardiomyogenic markers, YAP and HGF receptor expression using specific antibodies followed by secondary FITC-labelled antibodies or TRITC-
phalloidin. One representative out of the three experiments performed with similar results is shown. Scale bar, 50 μm. (B) For comparison, images of hCPCs
kept as monolayers at phase contrast microscope (top; scale bar 100 μm) or in immunofluorescence after staining for some of the samemarkers are shown
(20 x magnification).
doi:10.1371/journal.pone.0137999.g002
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samples correlated with the quantification obtained at protein levels, i.e, it was 4 times higher
in supernatants from 2D cultures, but still detectable in those from 3D spheroids (data not
shown). In cell extracts the protein expressed at higher levels was bFGF, followed by EGF,
which was present in significant amounts also in cells cultured as monolayers (Fig 4B). All the
other proteins were detectable at similar levels in the two conditions of cell growth, e.i. as
monolayers and as spheroids.
Another biological activity associated to stem cells and their migration potential particularly
important in regenerative responses of injured organs [36,37] is their invasiveness, which is
supported by lytic enzymes specific for the ECM components, such as MMPs [41]. qPCR anal-
ysis showed that in spheroids MMP2 was down-regulated, while the level of MMP14 tran-
scripts did not change (Fig 3). The lytic activities in the cell culture supernatants and in the
cell extracts were directly tested in a zymograph assay on gelatin (Fig 4C). Besides activated
MMP2, which was mainly detectable in spheroid supernatants, MMP9 and its precursor were
present at high levels in all samples, although in higher amounts in samples derived from 2D
cultures, both supernatant and cells. As in the case of growth factors and their receptors, the
fact that no perfect correlation was found between the mRNA and the protein analysis can
be partially explained by considering that mRNA was extracted after 1 day culture, while pro-
teins were analysed after 2 days of cell culture, to allow their secretion at detectable levels. All
together these data indicate that upon their spatial organization in 3D spheroids, hCPCs main-
tain easily detectable levels of MMPs, with a differential expression of the different isoforms.
This implies that these cells have not undergone important changes relative to their previous
culture conditions as 2D monolayers for what is their invasive potential.
The telomerase/telomere system provides an index of the cell growth potential and has also
been applied to hCPCs and their committed progeny [42,43]. Cells within spheroids were
found to display longer telomeres in comparison to cells in monolayers and a more significant
Fig 3. Gene expression of different growth factors, their receptors, ECMmolecules, adhesion/invasiveness components and cardiac markers in
spheroids andmonolayer cultures. Data from qPCR are expressed as fold variation of gene expression in spheroids normalized vsmonolayers (line).
Data are expressed as mean ± SD of at least three experiments. Significant difference of p0.05 is indicated as * and p0.001 is indicated as **.
doi:10.1371/journal.pone.0137999.g003
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elongation was observed in the cells derived from them after seeding and growth as monolayers
(p<0.001) (Fig 5A and 5C). The telomerase activity, which was measured in parallel, was
found to be transiently increased in 3D spheroids, but then reduced at basal levels in cells grow-
ing as monolayers after reseeding the spheroids (Fig 5B). These data indicate that hCPCs retain
the typical stem cell ability of activating/deactivating telomerase [42].
Fig 4. Protein expression of different growth factors, their receptors, and MMP activities. (A) Antibody-array analysis of protein expression in
supernatants (A) from 2Dmonolayers (left) and 3D spheroids (centre) and in cell extract (B) from 2Dmonolayers (left) and 3D spheroids (centre). Graphs on
the right represent fold variation of protein levels in spheroids normalized vsmonolayers (line). Data are expressed as mean ± SD of at least three
experiments. Significant difference of p0.05 is indicated as * and p0.0001 is indicated as **. (C) Activities of MMP-2 and MMP-9 present in culture
supernatants and cell extracts frommonolayers 2D or 3D spheroids of hCPCs in a Gelatin-substrate zymography. Arrows indicate location of enzymatic
activity corresponding to pro- and active forms of MMP-9 and MMP-2. Molecular weight markers (kDa) are shown on the left.
doi:10.1371/journal.pone.0137999.g004
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In vitro migration of hCPCs from spheroids
Since spheroids were projected for in vivo transplantation experiments, in which their cells
were expected to dissociate, migrate and eventually engraft, a wound healing assay was per-
formed to assess the in vitromigratory potential of the cells derived from them. The assay was
performed on confluent monolayers obtained from cells migrated from cultured spheroids. As
control reference, hCPCs were cultured in standard conditions. The assay also included an ago-
nist of the Met/HGF receptor [30] in order to evaluate the response to a possible pharmacologi-
cal modulation. Cells in both culture types migrated in response to 20% FBS. However, the
healing rate in the case of cells migrated from spheroid was higher, since wound healed in 16
hours (data not shown), while in the case of 2D cultures 24 hours were necessary for complete
healing (Fig 6A). The same trend was observed also upon Met/HGF receptor stimulation,
where a clear dose response migration of the cells at 24 hours is reported (Fig 6B).
hCPCs within spheroids engraft in the heart walls of C57/B6 mice
To evaluate the possibility that spheroids could be used as a fast delivery system for hCPCs in
vivo, they were injected into the left ventricular wall of immunosuppressed mice. Two
Fig 5. Telomere length (A) and telomerase expression (B). Variation in spheroids and reseeded spheroids vs monolayers. Data expressed as
mean ± SD. (C) Cell spreading from spheroids after reseeding on culture 2D plates. Scale bar 120 μm.
doi:10.1371/journal.pone.0137999.g005
Injectable Human Cardiac Progenitor Cell Spheroids
PLOS ONE | DOI:10.1371/journal.pone.0137999 September 16, 2015 13 / 23
sequential experiments were run. In the first set healthy animals were injected with the same
number of cells either in suspension upon release with trypsin and EDTA from monolayers or
in spheroids, and then sacrificed at different time points. At day 1 after transplantation, cell
spheroids were still clearly detectable, as shown by their staining with anti-human nuclei anti-
bodies (green nuclei, Fig 7A and 7B) and connexin 43 (red, Fig 7B). On the contrary, the
administration of the same amount of hCPCs as cell suspension did not allow a consistent
inclusion of human cells into the myocardium. At day 3 a number of cells migrated from
spheroids, as demonstrated by the loss of the compact spherical morphology and the presence
of dispersed cells into the myocardium matrix (Fig 7A and 7B). At the same time point, rare
and sparse hCPCs were detectable when administered as cell suspension. At day 7, hCPCs
derived from spheroids were still detectable, while no cells were detectable in the case of cell
Fig 6. Migratory activity of hCPCs kept as monolayers or of cells migrated from seeded spheroids (wound healing assay). (A) Quiescent cell
monolayers were “wounded” with a pipette tip and incubated for 24 hours in the absence (C-) or presence of 20% FBS (C+) or of different concentrations of
the HGF receptor agonist mAb DO-24 (5, 20, 80 nM respectively). (B) Quantitative analysis calculated as % variation of cell numbers in the rectangles
depicted in Fig 5A relative to untreated samples. The assay was repeated three times with triplicates and one representative assay is reported. Images were
taken at 5x magnification. After 24 hours healing was significantly induced by 20% FBS and mAb DO-24 treatments. Cells derived from spheroids (dark grey
bars) were more efficient than cells from 2D cultures at any condition (light grey bars).
doi:10.1371/journal.pone.0137999.g006
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Fig 7. In vivo transplantation of spheroids in healthy mice. (A) Myocardium sections frommice after
transplantation with hCPCs in suspension or as spheroids, at different time points, were stained with
TO-PRO3 (blue) to show all nuclei, anti-human nuclei antibody (green), and phalloidin (red) for actin and
analysed by confocal microscopy. (B) Myocardium sections frommice transplanted with spheroids were also
stained at different time points with TO-PRO3 (blue), anti-human nuclei antibody (green), and anti-connexin
43 (red). Representative experiments out of three performed are shown.
doi:10.1371/journal.pone.0137999.g007
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suspension injection. At this time point cells were fully dispersed within the myocardium wall
(Fig 7A and 7B).
The second set of experiments was aimed to assess if cells could engraft and survive in the
hostile environment induced by CTX injury, which mimics the damage induced by myocardial
infarction [32]. Myocardium injury was confirmed by hematoxilin-eosin staining (Fig 8A).
Also in this case spheroids were detectable one day after the injection (Fig 8B) and after one
week few cells were still present in the area of injury (Fig 8C). In both cases the injured site of
Fig 8. In vivo transplantation of spheroids in myocardium-injuredmice. (A) Evaluation of cardiotoxin-induced injury in the myocardium wall at two
magnifications (right) compared to healthy myocardium (left) in Hematoxylin-Eosin staining. (B) Myocardium sections frommyocardium injured mice
transplanted with spheroids were stained with TO-PRO3 (blue) to show all nuclei, anti-human nuclei antibody (green), and connexin-43 or phalloidin (red) for
actin and analysed by confocal microscopy. Representative experiments out of three performed are shown. The circle and arrows show the engrafted
spheroid 1 day after the injection and the dispersed hCPCs 7 days after the injection, respectively.
doi:10.1371/journal.pone.0137999.g008
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the myocardium was deeply infiltrated with mononuclear inflammatory cells. It can thus be
concluded that the cells can engraft in the injured myocardium.
Discussion
Stem cell therapy has always been envisaged as the possibility to repair injured heart by replac-
ing the dead cells [2,44]. The major obstacle to this approach is that most of the transplanted
cells, independently of their origin and histotype, are lost in a short time (>99% within 24h)
when administered as cell suspension [14]. This drawback could be partially overcome if cells
are administered in the form of aggregates, such as cardiospheres [6,12,45], cell sheets [20] or
sheet fragments [21]. The 2D/3D structures likely reproduce, at least in part, the natural envi-
ronment to which cells are accustomed, comprising a supporting ECM [46] In this work we
show that it is possible to produce spheroids of human CPCs with an easy, quick and cheap
approach and that cells within these spheroids maintain the markers of the original progenitor
cells, while enhancing some biological characteristics, such as proliferation and migration
potentials. Moreover, we show that this approach is suitable for producing spheroids that can
be transplanted in the heart wall, since, when transplanted in healthy or myocardium injured
mice, spheroids could release cells able to engraft and to remain detectable for at least 1 week.
Spheroids were generated using the temperature sensitive methylcellulose substrate and
were obtained with little manipulation (only one step) and in shorter time (less than 24h) in
comparison to other protocols used to prepare cell aggregates, such as cell sheets [20] and car-
diospheres [12]. The short time of culture necessary to obtain the spheroids allowed to main-
tain the expression of early commitment cardiac markers (c-kit, Sca-1, GATA-4, MEF2C,
MEF2D and connexin 43) as well as of the stemness/mesenchymal markers (CD90, CD44 and
vimentin). Furthermore, we demonstrate that cells into spheroids maintained the expression
and the release of many growth factors and the expression of their cognate receptors, which are
generally involved in cell homing, proliferation, survival, angiogenesis and motility [36].
Interestingly, spheroids show some differences in the levels of expression of some of these
factors compared to 2D monolayers, with the general tendency of their down-regulation. For
example, for SDF-1/CXCR4 axis, which mediates mainly cell homing to injured organ [47,48],
the ligand was down-regulated, but the receptor was up-regulated. In the case of IGF-1 and its
receptors, mostly involved in cells survival, proliferation and differentiation [49], the three
molecules were down regulated. HGF and VEGF, which are involved mainly in morphogene-
sis/tubulogenesis and vasculogenesis [50], were both upregulated, while their receptors were
down-regulated. The analysis of protein expression by the antibody array included also other
factors and revealed differential release of few factors. The more evident difference was that
spheroids released huge amounts of bFGF and significant amounts of IGFBP-1, the other
growth factors being generally released within the same range. All together, these data can sug-
gest a higher CXCR4- and bFGF-mediated homing potential of cells within spheroids, and an
increased potential to promote VEGF-mediated angiogenic responses in their microenviron-
ment. Indeed bFGF has been reported to enhance engraftment of mesenchymal stem cells for
cardiac repair better than VEGF and IGF-1 [25] by protecting cells from the post-ischemic
microenvironment [51]. Concordantly, the main proteins expressed by cells, both in 2D and in
3D, were bFGF and IGFBP-1. The lower expression of IGF in supernatants of spheroids could
be compensated by the higher expression and release of IGFBP-1, which can stabilize the
short-lived circulating IGF [52]. Also the VE-cad2 endothelial marker was shown to be up-reg-
ulated in spheroids. Spheroids contained highly viable cells, likely because their size around
100 μm is largely within the limits of oxygen diffusion in compact highly cellularized tissues
and the short time needed for their assembly. The fact that cells in spheroids show some
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neovascularization potential is noteworthy and could predispose for the oxygenation require-
ment of cells in solid compacted structures after the engraftment [53]. The decreased expres-
sion of Met, which anyway was still detectable in immunofluorescence, did not affect the
capability of the cells migrated from spheroids to respond to HGF in a motility assay, such as
wound healing.
Cells in spheroids displayed a higher replicative potential relative to cells in monolayers,
since they showed an increased length of telomeres. An even more significant elongation was
observed in the cells derived from spheroids, which were reseeded and grown as monolayers.
The increased telomere length was supported by an increased level in the expression of telome-
rase, which provided an index of the growth potential of hCPCs and of their committed prog-
eny. Strong activation of telomerase has been detected in most human tumour tissues, while
normal somatic cells lack this activity. Germinal and stem cells are able to activate at low levels
or to down-regulate this enzyme, depending on the replicative needs of the cells [54]. The
observed increased activity of telomerase in spheroids in respect to monolayers may indicate
that the spheroid condition predispose cells to replication. Furthermore, cells derived from
spheroids after seeding on culture plates were able to down-regulate telomerase at a level typi-
cal of the cells grown as monolayers. Thus after telomerase reactivation, the cells that origi-
nated from spheroids down-regulated it to basal levels since a sufficient telomere length was
achieved to sustain proliferation [55]. These data suggest that the culture condition in spher-
oids has the effect of rejuvenating hCPCs, which acquire the potential of more cell cycles [56].
This observation is in line with what recently reported for cells from ciliary body, which, if in
spheroids, could be reprogrammed in the presence of only Oct4, not requiring Klf4, which oth-
erwise was necessary if cells were maintained as monolayers [57]. The fact that hCPCs are able
to modulate positively and negatively telomerase depending on the culture conditions is note-
worthy, since it indicates that the cells have not a tumoral behaviour but retain a stem cell pro-
file. The proliferative potential of cells within spheroids is also in line with their expression of
YAP, a transcriptional cofactor involved in Hippo signalling pathway [58]. YAP promotes pro-
liferation of embryonic cardiomyocytes by activating the insulin-like growth factor and Wnt
signalling pathways and acting as dynamic sensor of substrate mechanics. Moreover, its consti-
tutively activated form can stimulate cardiac regeneration in the adult heart and can improve
contractility after myocardial infarction in mice [33]. These data, apparently contradictory
with the observed down-regulation of the IGF-1 axis, can be reconciled by supposing that cells
in spheroids acquire a more stemness phenotype, i.e. they are more quiescent, but have an
enhanced proliferation potential that they will display once spheroids are reseeded in 2D cul-
tures. Similar conclusions were reached when cardiospheres, which are spontaneously gener-
ated by culturing in suspension clones of cells derived from heart biopsies, and cells dissociated
from them and cultured as monolayers, were compared [45].
Cells within spheroids displayed also good tissue adhesive properties: indeed they synthetize
ECM components (collagen I, collagen IV, laminin, fibronectin), and in the meantime express
integrins at their surfaces. Also in this case, cells in spheroids displayed the tendency to lower
the expression of most of these molecules; however, they were clearly detectable in immunoflu-
orescence. These molecules are important not only for adhesion and migration; they can also
impart signalling for cell survival, proliferation and differentiation [38,59] which are trans-
duced within cells through integrin receptors [39,40]. In these pleiotropic cell responses, signals
from ECM and growth factors act in dynamic cooperation, both in vitro and in vivo [60]. Cells
in spheroids displayed also a superior propensity for migration than cells grown as monolayers,
as shown in the wound healing assay. We also assayed the effects of a possible pharmacological
modulation of this process by using an HGF receptor agonist. HGF was chosen as a prototype
growth factor, since it is a recognized motogenic factor for mesenchymal stem cells of different
Injectable Human Cardiac Progenitor Cell Spheroids
PLOS ONE | DOI:10.1371/journal.pone.0137999 September 16, 2015 18 / 23
origin and species in vitro [61], ex vivo [48] and in vivo [49], and in particular was applied in
the field of myocardium. Moreover, compared to SDF-1, a different homing factor, HGF has
already shown to promote cardiac commitment [49,61] anti-apoptotic activity on cardiomyo-
blasts [31] and in vivo cardioprotection [62]. On the other side HGF is only one of the many
growth factors and cytokines released from injured organs to recruit cells for their regeneration
and repair [36]. Finally, also the expression, release and activity of matrix metalloproteases
(MMPs)-molecules known to play a role in MSC migration [63]- suggested that spheroids had
acquired a more favourable migratory and engraftment phenotype compared to monolayer
cultures. In details MMP-9 lytic activity was lower in both supernatants and cell extracts from
spheroids, while MMP-2 activity was secreted only by spheroids. Down-regulation of MMP-9
in myogenic cells enhances their engraftment in dystrophic muscle [64], and thus its slight
decrease in spheroids could explain their better engraftment ability. By contrast, an increase of
MMP-2 was associated with a better migration, proliferation and engraftment of low adherent
skeletal myoblasts [65]. Thus, the spheroid phenotype, while maintaining all the properties of
the cells cultured as monolayers, seems to be more appropriate for the in vivo administration
than their counterpart derived from 2D cultures.
We performed in vivo experiments to support these hypotheses and the data, although pre-
liminary, confirmed these expectations. hCPCs derived from spheroids remained detectable in
the myocardium of healthy C57/B6 mice for at least 1 week after transplantation. Furthermore
they were able to migrate from spheroids and to disperse in the cardiac matrix, while cells
injected as suspensions were barely detectable 1 day after transplantation. These data are in
line with those reported by Li et al., 2010, who compared the in vivo fate of cardiospheres vs
cells dissociated from them [45]. These observations are probably due to the fact that spheroids
can entrap into the myocardial interstices and can facilitate ECM-mediated engraftment. We
planned short time point experiments since the goals of these preliminary in vivo data were to
confirm the potential of this rapid technique and to show the impact of this procedure on cell
phenotype. Due to this short time of observation cells are not expected to undergo significant
differentiation. Furthermore, we have chosen a low number of cells to be transplanted as spher-
oids in contrast to similar experiments performed with cell aggregates, i.e. cell sheets [19,20] or
cardiospheres [12,66], in order to reproduce a more realistic scenario for hCPC transplanta-
tion. Future long term experiments focusing on the recovery of the cardiac function in specific
in vivomodels will definitively elucidate the real potential of this procedure, although our pre-
liminary data herein show that the spheroids prepared with this methodology are able to
engraft also in a model of myocardial infarct.
Besides the advantage linked to their physical status of cell aggregates shown by the in vivo
experiments described above, spheroids has the additional advantage to better preserve stem
cell properties, i.e. self-renewal through stable telomere length and migration ability triggered
by growth factors and cytokines. These traits, which are typical of embryonic stem cells during
development, are essential for the regeneration and healing of injured organs in adults. Indeed
a phase 2 trial with cardiospheres, similarly shaped multicellular structures, are already under
way [6]. Herein we show that ready-to-implant scaffold-less aggregates of human cardiac pro-
genitor cells can be produced with an easy, economic and fast protocol, thus making spheroids
good candidates for future cell therapies applied to myocardium, drug discovery and screening.
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